FIELD: medicine, experimental virology. SUBSTANCE: to enhance curative effect and prophylaxis activity 4-iodoantipyrine is administrated at tick-borne encephalitis as an antiviral agent. EFFECT: enhanced efficacy of agent proposed. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT ELICITING PROPHYLACTIC AND CURATIVE EFFECT IN INFECTION WITH TICK-BORNE ENCEPHALITIS VIRUS | 2003 |
|
RU2242238C1 |
METHOD FOR PREVENTION AND TREATMENT OF DANGEROUS NEUROVIRAL INFECTIONS | 2016 |
|
RU2642312C1 |
MEDICINAL AGENT AND METHOD FOR TREATMENT OF GENITAL POINTED CONDYLOMATOSIS | 2002 |
|
RU2221562C1 |
ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
ANTIVIRAL AGENT FOR PREVENTING AND TREATING TICK-BORNE ENCEPHALITIS | 2010 |
|
RU2444363C2 |
METHOD AND AGENT ACTIVATING IRF-3 FOR TREATING AND PREVENTING DISEASES CAUSED BY (+) RNA CONTAINING VIRUSES | 2012 |
|
RU2518314C2 |
SOLID DOSAGED FORM FOR ORAL USING SHOWING ANTIVIRAL ACTIVITY (VARIANTS) | 1995 |
|
RU2115415C1 |
METHOD OF PREPARING ANTIBODIES FOR MITE ENCEPHALITIS VIRUS DIAGNOSTIC PREPARATION PRODUCTION | 1993 |
|
RU2063245C1 |
ANTIVIRAL IMMUNOMODULATING AGENT | 2001 |
|
RU2202547C2 |
ANTIVIRAL PREPARATION | 1994 |
|
RU2071323C1 |
Authors
Dates
1994-12-30—Published
1986-09-09—Filed